SCHEMBL19919630

SCHEMBL19919630

N#Cc1ccc2c(c1)c1ccccc1n2-c1cc(-c2cc(-c3ccccc3)nc(-c3ccccc3)c2)c(-n2c3ccccc3c3cc(C#N)ccc32)cc1C#N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 2/20 0.39
ABCB1 P08183 1/20 0.39
MYC P01106 1/20 0.39
CSNK2A1 P68400 2/20 0.37
JAK2 O60674 1/20 0.37
PRKD3 O94806 1/20 0.37
ABL1 P00519 1/20 0.37
EGFR P00533 1/20 0.37
ERBB2 P04626 1/20 0.37
LCK P06239 1/20 0.37
CDK1 P06493 1/20 0.37
CSF1R P07333 1/20 0.37
LYN P07948 1/20 0.37
RET P07949 1/20 0.37
KIT P10721 1/20 0.37
FGFR1 P11362 1/20 0.37
FER P16591 1/20 0.37
FLT1 P17948 1/20 0.37
FGFR3 P22607 1/20 0.37
KDR P35968 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19909518 0.98 ABCG2 (0.40) ABCG2ABCB1MYCCSNK2A1JAK2
SCHEMBL19913210 0.93 ABCG2 (0.39) ABCG2ABCB1MYCCSNK2A1JAK2
SCHEMBL22170442 0.93 MYC (0.44) ABCG2ABCB1MYCCSNK2A1GABRG2
SCHEMBL19919754 0.92 MYC (0.38) ABCG2ABCB1MYCCSNK2A1JAK2
SCHEMBL19919712 0.92 ALDH1A3 (0.43) MYCCLK4GABRG2GABRB3GABRA5
SCHEMBL23487606 0.91 CLK4 (0.39) ABCG2ABCB1MYCCSNK2A1JAK2
SCHEMBL22562342 0.90 CLK4 (0.36) ABCG2ABCB1MYCCSNK2A1JAK2
SCHEMBL19919752 0.90 MYC (0.46) ABCG2ABCB1MYCCSNK2A1JAK2
SCHEMBL19909529 0.90 MYC (0.37) MYCCSNK2A1GABRG2GABRB3GABRA5
SCHEMBL19909332 0.90 MYC (0.41) ABCG2ABCB1MYCCSNK2A1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 ABCG2 624/4885ABCB1 161/4885MYC 1697/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 ABCG2 3492/4885ABCB1 2129/4885MYC 1636/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 ABCG2 624/4885ABCB1 161/4885MYC 1697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.